RXRX filings
Corporate insider profile
Najat Khan Filing Activity
Latest reported as CEO and President of RECURSION PHARMACEUTICALS, INC. (RXRX).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$84,459.19
- Latest transaction
- Jun 5, 2026
Affiliated corporations
Reported company relationships
Transaction history
